Maxnerva Technology Services Limited (Stock code: 1037) released additional information regarding the 2024 Annual Report. The supplemental disclosure centers on the Share Option Scheme, including the non-refundable application amount of HK$1.00 for each share option offer and a 21-day acceptance period.

Updates detail that share options remain subject to specified vesting periods before their respective exercise windows begin. As of 31 December 2024, there were 15,220,000 granted share options outstanding at the start of the year, with 3,670,000 forfeited during the period and no exercises or expirations. This resulted in 11,550,000 share options remaining as of year-end. Comparatively, 16,120,000 were outstanding at the start of 2023, with 900,000 forfeited over the course of that year, leaving 15,220,000 as of 31 December 2023.

The announcement states that all other information in the 2024 Annual Report remains unchanged. The Board notes that the chair and directors continue to serve as disclosed, and that no further adjustments have been made to previously released figures and statements.